Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	572.83	466.39	498.72	437.03	336.55	430.86
Short-Term Investments	-	263.97	322.21	342.83	-	-
Trading Asset Securities	13.06	-	-	-	-	52.2
Cash & Short-Term Investments	585.89	730.35	820.93	779.86	336.55	483.06
Cash Growth	-30.73%	-11.03%	5.27%	131.72%	-30.33%	159.83%
Accounts Receivable	261.08	262.44	261.25	297.24	232.03	191.8
Other Receivables	38.09	54.72	27.59	25.22	26.26	13.89
Receivables	299.18	317.16	288.84	322.46	258.29	205.69
Inventory	250.69	232.07	220.37	200.57	193.5	148.18
Other Current Assets	47.09	54.1	41.26	33	41.41	29.53
Total Current Assets	1,183	1,334	1,371	1,336	829.76	866.46
Property, Plant & Equipment	900.66	911.18	888.73	737.85	584.72	442.18
Long-Term Investments	13.12	13.84	8.53	8.69	9.83	5.5
Goodwill	25.15	25.15	40.67	127.13	127.13	136.59
Other Intangible Assets	99.61	101.63	98.08	94.51	90.51	89.38
Long-Term Accounts Receivable	12.18	4.12	5.59	-	-	-
Long-Term Deferred Tax Assets	29.51	29.19	18.13	25	10.48	6.03
Long-Term Deferred Charges	39.39	39.81	40.85	25.91	31.85	30.13
Other Long-Term Assets	104.99	40.21	62.43	83.97	35.24	30.9
Total Assets	2,407	2,499	2,534	2,439	1,720	1,607
Accounts Payable	206.43	206.49	246.8	221.26	178.44	133.13
Accrued Expenses	30.27	43.5	38.87	49.57	37.35	57.31
Short-Term Debt	138.53	188.14	220.41	132.64	130.66	105.5
Current Portion of Long-Term Debt	37.75	40.7	50.37	14.55	8.06	-
Current Portion of Leases	5.83	6.65	6.45	5.95	4.47	-
Current Income Taxes Payable	0.64	1.98	3.08	3.98	3.37	7.17
Current Unearned Revenue	40.86	43.75	69.39	76.01	48.08	47.65
Other Current Liabilities	80.24	144.61	135.34	99.43	86.77	43.89
Total Current Liabilities	540.55	675.82	770.7	603.39	497.2	394.65
Long-Term Debt	436.57	388.05	284.16	252.97	205.21	162.21
Long-Term Leases	20.63	22.19	23.61	21.46	8.12	-
Long-Term Unearned Revenue	103.21	106.94	50.3	45.38	9.32	10.4
Long-Term Deferred Tax Liabilities	10.8	14.72	14.87	13.48	7.25	7.07
Other Long-Term Liabilities	-	-	1.81	-	0.03	-
Total Liabilities	1,112	1,208	1,145	936.68	727.13	574.33
Common Stock	264.58	264.58	264.58	175.79	146.09	146.09
Additional Paid-In Capital	408.04	408.04	408.03	504.38	-	15.83
Retained Earnings	514.35	513.04	584.48	684.82	698.15	701.16
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	54.75	53.04	53.81	51.09	49.64	54.85
Total Common Equity	1,222	1,219	1,311	1,416	893.89	917.93
Minority Interest	74.02	72.43	78.05	86.17	98.49	114.9
Shareholders' Equity	1,296	1,291	1,389	1,502	992.38	1,033
Total Liabilities & Equity	2,407	2,499	2,534	2,439	1,720	1,607
Total Debt	639.31	645.72	584.99	427.57	356.52	267.71
Net Cash (Debt)	-53.42	84.63	235.94	352.29	-19.97	215.35
Net Cash Growth	-	-64.13%	-33.03%	-	-	12617.43%
Net Cash Per Share	-0.20	0.32	0.89	1.35	-0.09	0.98
Filing Date Shares Outstanding	261.6	261.6	264.58	263.68	262.22	219.13
Total Common Shares Outstanding	261.6	261.6	264.58	263.68	219.14	219.13
Working Capital	642.3	657.87	600.7	732.5	332.56	471.81
Book Value Per Share	4.67	4.66	4.95	5.37	4.08	4.19
Tangible Book Value	1,097	1,092	1,172	1,194	676.25	691.96
Tangible Book Value Per Share	4.19	4.17	4.43	4.53	3.09	3.16
Buildings	583.56	582.36	308.84	244.21	216.58	224.73
Machinery	518.77	448.39	418.44	398.3	361.28	283.82
Construction In Progress	75.63	127.92	365.74	263.45	155.7	71.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.